Good At

He specializes in interventional treatment of coronary heart disease, heart valve disease, and congenital heart disease, atrial fibrillation and left atrial appendage closure, and drug treatment of hypertension and hyperlipidemia.

Introduction

Jin Shuxuan, male, MD, chief physician, director of cardiac catheterization room. He has been engaged in interventional work since 2001, with more than 700 interventional surgeries per year. Longer than a variety of complex lesions, such as: interventional treatment of completely occluded lesions (antegrade and retrograde surgery), calcified lesions, left main trunk and bifurcation, bridging vessel lesions, etc.; and coronary artery fistula closure, chemical ablation of hypertrophic obstructive cardiomyopathy and local thrombus fragmentation of acute critical pulmonary embolism. Member of the Pulmonary Vascular Disease Group of the 11th Committee of the Cardiovascular Disease Branch of the Chinese Medical Association; Deputy Leader of the Heart Failure Group of the 11th Special Committee of the Shanghai City Branch of the Chinese Medical Association; Standing Member of the Youth Committee for the Prevention and Treatment of Cardiovascular Disease of the Association for the Advancement of Medical Sciences; Instructor of the National Cardiovascular Disease Interventional Diagnosis and Treatment Technology Training Base (Coronary Heart Disease Intervention); member of CTOCC; member of CTO veteran buddy; member of China Rotary Rhetoric Mentors Group; Member of the CIT working group; member of the presidium of domestic mainstream academic conferences (CIT, OCT, etc.); member of the presidium of foreign mainstream academic conferences (TCT AP 2016; TCT 2016, etc.); participated in domestic and foreign professional conferences many times as host, discussant, speaker and surgical demonstrations. Hosted 1 experimental animal research project of the Shanghai City Science and Technology Commission; participated in many NSFC projects; and published more than ten SCI papers. First prize in 2014 Shanghai City Medical Science and Technology Award (4th completer); first prize in 2016 Ministry of Education Science and Technology Progress Award (5th completer).